A Mobile App to Stabilize Daily Functional Activity of Breast Cancer Patients in Collaboration With the Physician: A Randomized Controlled Clinical Trial
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The well-being of breast cancer patients and reporting of adverse events require close monitoring. Mobile apps allow continuous recording of disease- and medication-related symptoms in patients undergoing chemotherapy. OBJECTIVE: The aim of the study was to evaluate the effects of a mobile app on patient-reported daily functional activity in a supervised and unsupervised setting. METHODS: We conducted a randomized controlled study of 139 breast cancer patients undergoing chemotherapy. Patient status was self-measured using Eastern Cooperative Oncology Group scoring and Common Terminology Criteria for Adverse Events. Participants were randomly assigned to a control group, an unsupervised group that used a mobile app to record data, or a supervised group that used the app and reviewed data with a physician. Primary outcome variables were change in daily functional activity and symptoms over three outpatient visits. RESULTS: Functional activity scores declined in all groups from the first to second visit. However, from the second to third visit, only the supervised group improved, whereas the others continued to decline. Overall, the supervised group showed no significant difference from the first (median 90.85, IQR 30.67) to third visit (median 84.76, IQR 18.29, P=.72). Both app-using groups reported more distinct adverse events in the app than in the questionnaire (supervised: n=1033 vs n=656; unsupervised: n=852 vs n=823), although the unsupervised group reported more symptoms overall (n=4808) in the app than the supervised group (n=4463). CONCLUSIONS: The mobile app was associated with stabilized daily functional activity when used under collaborative review. App-using participants could more frequently report adverse events, and those under supervision made fewer and more precise entries than unsupervised participants. Our findings suggest that patient well-being and awareness of chemotherapy adverse effects can be improved by using a mobile app in collaboration with the treating physician. CLINICALTRIAL: ClinicalTrials.gov NCT02004496; https://clinicaltrials.gov/ct2/show/NCT02004496 (Archived by WebCite at http://www.webcitation.org/6k68FZHo2).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Basch, E., Deal, A. M., Kris, M. G., Scher, H. I., Hudis, C. A., Sabbatini, P., Rogak, L., Bennett, A. V., Dueck, A. C., Atkinson, T. M., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.0830 · Cited by 2,593
A Systematic Review of Healthcare Applications for Smartphones
Mosa, A. S. M., Yoo, I., & Sheets, L. (2012) · BMC Medical Informatics and Decision Making · doi:10.1186/1472-6947-12-67 · Cited by 1,184 · cited 1×
“Mobile apps increasingly contribute to patient education, disease self-management, and remote monitoring of patients [12].”
BackgroundDetmar, S. B., Muller, M. J., Schornagel, J. H., Wever, L. D. V., & Aaronson, N. K. (2002) · JAMA · doi:10.1001/jama.288.23.3027 · Cited by 1,011 · cited 1×
“Previous studies also indicate that physicians, as well as the majority of patients, believe that mobile apps facilitate communication [10] and increase the frequency of discussion [11] during consultations.”
Cited by
Qudah, B., & Luetsch, K. (2019) · Patient Education and Counseling · doi:10.1016/j.pec.2019.01.021 · Cited by 200
Seiler, A., Klaas, V., Tröster, G., & Fagundes, C. P. (2017) · Psycho-Oncology · doi:10.1002/pon.4489 · Cited by 176
Research-Tested Mobile Apps for Breast Cancer Care: Systematic Review
Jongerius, C., Russo, S., Mazzocco, K., & Pravettoni, G. (2019) · JMIR mHealth and uHealth · doi:10.2196/10930 · Cited by 146
Zhu, J., Ebert, L., Liu, X., Wei, D., & Chan, S. W.-C. (2018) · JMIR mHealth and uHealth · doi:10.2196/mhealth.9438 · Cited by 124
“A dropout rate ranging from 10% to 20% was reported in previous studies involving an app-based study [9,26].”
BackgroundRincon, E., Monteiro-Guerra, F., Rivera-Romero, O., Dorronzoro-Zubiete, E., Sanchez-Bocanegra, C. L., & Gabarron, E. (2017) · JMIR mHealth and uHealth · doi:10.2196/mhealth.8741 · Cited by 108
Evidence on the Use of Mobile Apps During the Treatment of Breast Cancer: Systematic Review
Cruz, F. O. A. M., Vilela, R. A., Ferreira, E. B., Melo, N. S., & Reis, P. E. D. D. (2019) · JMIR mHealth and uHealth · doi:10.2196/13245 · Cited by 66
“Only one of the studies [18] presented high risk in 2 domains, both regarding blinding; the authors indicated that the absence of blinding may have affected the outcomes evaluated.”
InfluentialHuang, Y., Li, Q., Zhou, F., & Song, J. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-057664 · Cited by 36
A systematic review of eHealth technologies for breast cancer supportive care
Gyawali, B., Bowman, M., Sharpe, I., Jalink, M., Srivastava, S., & Wijeratne, D. T. (2023) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2023.102519 · Cited by 28
Cancer Patients’ and Survivors’ Perceptions of the Calm App: Cross-Sectional Descriptive Study
Huberty, J., Puzia, M., Eckert, R., & Larkey, L. (2020) · JMIR Cancer · doi:10.2196/16926 · Cited by 18
“In breast cancer patients, multiple studies support the feasibility and acceptability of using mobile apps to monitor symptoms related to sleep [52], daily functional activity [53], and mental health [54].”
Background
Metadata
- Authors
- Egbring, M., Far, E., Roos, M., Dietrich, M., Brauchbar, M., Kullak-Ublick, G. A., & Trojan, A.
- Venue
- Journal of Medical Internet Research
- Publisher
- JMIR Publications Inc.
- Published
- 2016-09-06
- Volume
- 18
- Issue
- 9
- Pages
- e238
- ISSN
- 1438-8871 (ISSN-L)
- OpenAlex
- W2512462499
- Cited by
- 93
- References
- 3
- FWCI
- 14.54
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.